Search
B
Bedmutha Industries Ltd
Score 68/100
• Decent
Bedmutha Industries Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
Company’s Health63/100
Valuation
80/100 · PB 1.2292
Technical
Avoid
1M -17.405%
6M -36.877%
1Y -52.802%
Confidence100%
M
Mold-Tek Technologies Ltd
Score 68/100
• Decent
Mold-Tek Technologies Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
Company’s Health78/100
Valuation
40/100 · PB 3.9205
Technical
Avoid
1M -11.448%
6M 0.634%
1Y -26.259%
Confidence100%
I
Infollion Research Services Ltd
Score 68/100
• Decent
Infollion Research Services Ltd shows potential but faces challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health93/100
Valuation
20/100 · PB 7.4978
Technical
Avoid
1M 7.042%
6M -12.203%
1Y -17.399%
Confidence100%
P
Pavna Industries Ltd
Score 68/100
• Decent
Pavna Industries Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
Company’s Health68/100
Valuation
80/100 · PB 1.811
Technical
Avoid
1M -19.709%
6M -38.143%
1Y -47.928%
Confidence100%
M
Medicamen Biotech Ltd
Score 68/100
• Decent
Medicamen Biotech Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
Company’s Health62/100
Valuation
60/100 · PB 2.5789
Technical
Avoid
1M -3.326%
6M -3.225%
1Y -29.123%
Confidence100%
G
Grand Continent Hotels Ltd
Score 68/100
• Decent
While Grand Continent Hotels Ltd shows potential in a recovering sector, inconsistencies in growth and profitability metrics warrant caution.
Company’s Health88/100
Valuation
40/100 · PB 3.7638
Technical
Avoid
1M -7.059%
6M 23.394%
1Y 59.347%
Confidence100%
B
Brooks Laboratories Ltd
Score 68/100
• Decent
Brooks Laboratories Ltd shows potential in a growing sector, but faces challenges in growth consistency and profitability metrics.
Company’s Health55/100
Valuation
60/100 · PB 2.9436
Technical
Avoid
1M -6.098%
6M -22.19%
1Y -33.712%
Confidence100%
V
Valiant Laboratories Ltd
Score 68/100
• Decent
Valiant Laboratories Ltd shows potential but faces challenges in profitability and growth drivers.
Company’s Health75/100
Valuation
80/100 · PB 1.5498
Technical
Avoid
1M -16.904%
6M -37.168%
1Y -40.33%
Confidence100%
V
Vision Infra Equipment Solutions Ltd
Score 68/100
• Decent
While Vision Infra Equipment Solutions Ltd operates in a growing sector, its inconsistent financial performance and high valuation metrics suggest caution. The company has potential but faces significant execution risks.
Company’s Health84/100
Valuation
40/100 · PB 4.1043
Technical
Avoid
1M -4.164%
6M 62.172%
1Y 52.582%
Confidence100%
A
Aditya BSL Nifty 50 ETF
Score 68/100
• Decent
The Aditya BSL Nifty 50 ETF presents a decent investment opportunity with a stable outlook, driven by the performance of its underlying assets.
Company’s Health0/100
Valuation
0/100 · PB —
Technical
Avoid
1M 0.069%
6M 5.911%
1Y -4.529%
Confidence80%
K
Kriti Nutrients Ltd
Score 68/100
• Decent
Kriti Nutrients Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
Company’s Health98/100
Valuation
80/100 · PB 1.5188
Technical
Avoid
1M -22.196%
6M -45.581%
1Y -54.447%
Confidence100%
J
Jenburkt Pharmaceuticals Ltd
Score 68/100
• Decent
Jenburkt Pharmaceuticals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health84/100
Valuation
60/100 · PB 2.7994
Technical
Avoid
1M -16.667%
6M -14.973%
1Y -17.773%
Confidence100%
S
Supreme Power Equipment Ltd
Score 68/100
• Decent
While Supreme Power Equipment Ltd operates in a promising sector, its inconsistent growth and profitability metrics raise concerns. Caution is advised for potential investors.
Company’s Health95/100
Valuation
20/100 · PB 5.3001
Technical
Avoid
1M 6.042%
6M 11.354%
1Y -14.087%
Confidence100%
U
Ugar Sugar Works Ltd
Score 68/100
• Decent
Ugar Sugar Works Ltd shows potential but faces challenges in growth consistency and profitability metrics. Investors should be cautious.
Company’s Health44/100
Valuation
60/100 · PB 2.3391
Technical
Avoid
1M 4.86%
6M -8.979%
1Y -38.412%
Confidence100%
R
Rama Phosphates Ltd
Score 68/100
• Decent
Rama Phosphates Ltd shows potential in a critical sector but faces challenges in growth consistency and valuation metrics.
Company’s Health53/100
Valuation
80/100 · PB 1.4919
Technical
Avoid
1M -23.314%
6M 25.04%
1Y 56.437%
Confidence100%